{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-058018","form_type":"8-K","ticker":"ASTH","cik":"0001083446","company_name":"Astrana Health, Inc.","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.213008+00:00","generated_at":"2026-06-02T15:53:04.570999+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Astrana Q1 revenue $404.4M (+20% YoY), net income $14.8M (+13%), EPS $0.31","bullets":["Total revenue $404.4M (+20% YoY); net income attributable $14.8M (+13%); diluted EPS $0.31 (+11%).","Adjusted EBITDA $42.2M (+42% YoY); full-year 2024 guidance reaffirmed: revenue $1.65-1.85B, adj. EBITDA $165-185M.","Completed largest acquisition (CFC) on Mar 31 and acquired PCCCV (~26K Medicaid members) on Mar 29.","Organic membership growth 10% YTD; total lives ~1M; full-risk capitation expected ~60% of total capitation revenue as of Apr 1.","Opened two new de novo clinics in Nevada in April."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-058018","json":"https://secwatch.observer/filing/0001104659-24-058018.json","markdown":"https://secwatch.observer/filing/0001104659-24-058018.md","text":"https://secwatch.observer/filing/0001104659-24-058018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1083446/000110465924058018/0001104659-24-058018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1083446/000110465924058018/tm2413600d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T15:53:04.570999+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"12cb6f28afdac9312589f0ffea17c466e7e68969","claim":"Astrana Health, Inc. updated its first quarter ended March 31, 2024 guidance (reaffirmed).","evidence_excerpt":"On May 7, 2024, Astrana Health, Inc. (the \"Company\") issued a press release announcing its financial results for the three months ended March 31, 2024. A copy of the press release and supplemental data is furnished with this Current Report on Form 8-K as Exhibit 99.1 and Exhibit 99.2, respectively, and incorporated herein by reference.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465924058018/0001104659-24-058018-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}